Mono and dinuclear bis(ortho-tolyl)platinum(II) compounds containing diethyl sulfide ligands: Synthesis, DFT studies and use as precursors in cycloplatination reactions

The synthesis of bis(ortho-tolyl)platinum(II) compounds containing diethyl sulfide ligands from [PtCl2(SEt2)2] and ortho-tolyl-lithium is presented. Formation of a dimer [Pt(4-MeC6H4)2(μ-SEt2)]2 is evidenced by 1H NMR and HR-MS-ESI(+) spectra and the monomer trans-anti-[Pt(2-MeC6H4)2(SEt2)2] is characterized by X-ray diffraction analyses. Theoretical studies indicate that dimerization of the most stable form of the monomer (cis-syn) to the most stable conformer of the dinuclear species (αββα) is favored (ΔE = −10.1 kJ/mol). The reactions of the dimer [Pt(4-MeC6H4)2(μ-SEt2)] with imine ligands 4-ClC6H4CH = NCH2CH2NMe2 and 2-Br,6-FC6H3CH = NCH2Ph gave a tridentate [C, N, N'] five-membered and a bidentate [C, N] seven-membered platinacycles, respectively

Synthesis and crystal structure of the dinuclear cyclopalladated compounds of methyl (E)-4-(benzylideneamino)benzoate with acetato and chlorido bridge ligands: Study of their splitting reactions with pyridine

Reaction of methyl (E)-4-(benzylideneamino)benzoate C6H5CH=N(C6H4-4-CO2Me) with Pd(OAc)(2) produced the dinuclear acetato bridge ortho-cyclopalladated compound [Pd{C6H4CH=N(C6H4-4-CO2Me)-kappa C-ortho,kappa(N)}](2)(mu-OAc)(2) (1). Compounds [Pd{C6H4CH=N(C6H4-4-CO2Me)-kappa C-ortho,kappa(N)}](2)(mu-Cl)(2) (2) and [Pd {C6H4CH] N(C6H4-4-CO2Me)-kappa C-ortho,kappa(N)}(py)(X)] [3 (X = OAc); 4 (X = Cl)] were also prepared and isolated in good yields by substitution reactions. H-1 and C-13{H-1} NMR in CDCl3 solution of compounds 3 and 4 revealed that they consisted of a mixture of trans-and cis-N,N isomers. Addition of pyridine-d(5) to solutions of 1 and 2 in CDCl3 in a molar ratio pyridine-d(5)/1 or 2 approximate to 50-55 gave solutions A and B, respectively, which contained compounds 5 and 6 analogous to 3 and 4, but with pyridine-d(5) rather than pyridine in their structural formula. In these solutions, the trans-and cis-N,N geometrical isomers of compounds 5 and 6 were interconverting between them in a dynamic equilibrium. In addition, an exchange between free and coordinated pyridine-d(5) was also taking place in solutions A and B. The NMR data for solution A showed that the dynamic equilibrium between the cis-and trans-N,N isomers of compound 5 was shifted to the trans-N,N isomer. However, the NMR data for solution B suggested that in this solution the equilibrium between the cis- and trans-N,N isomers of compound 6 was shifted to the cis-N,N isomer. Interconversion between the trans- and cis-N,N isomers of compounds 5 and 6 in solutions A and B plausibly proceeded through the intermediate ionic complexes [Pd{C6H4CH] N(C6H4-4CO(2)Me)-kappa C-ortho,kappa(N)}(py-d(5))(2)]X [7 (X = OAc), 8 (X = Cl)]. Ionic complexes 7 and 8 were not observed in CDCl3 solution but were the major species in D2O solutions containing compounds 1 and 2 and pyridine-d(5) in a molar ratio pyridine-d(5)/1 or 2 approximate to 50-55. The crystal structure of the adduct 1.2(CH3COOH) and that of compound 2 were determined by single crystal X-ray diffraction. A theoretical study on the difference in free Gibbs energy in CHCl3 solution between the cis-and trans-N,N isomers of compounds 3 and 4 is also included in this work

Platinum(II) and palladium(II) complexes derived from 1-ferrocenylmethyl-3,5-diphenylpyrazole. Coordination, cyclometallation or transannulation?

The synthesis and characterization of the novel pyrazole derivative [1-(Fc-CH2)-3,5-Ph-2-(C3HN2)] (2) {Fc = (eta(5) -C5H5)Fe(eta(5)-C5H4)-} with a ferrocenylmethyl substituent on position 1 of the heterocycle is described. The study of the reactivity of 2 with cis-[MCl2L2] (M = Pt and L = dmso or M = Pd and L = dmso or CH3CN), Pd(AcO)(2) or Na-2[PdCl4] under different experimental conditions, has allowed us to isolate and characterize a wide variety of platinum(II) or palladium(II) complexes: trans-[Pt{1-(Fc-CH2)-3,5-Ph2-(C3HN2)} Cl-2(dmso)] (3), the cis-isomers of [M{1-(Fc-CH2)-3,5-Ph-2-(C3HN2)}Cl-2(dmso)] {M = Pt (4) or Pd (7)}, trans-[Pd{1-(Fc-CH2)-3,5-Ph-2-(C3HN2)}(2)Cl-2] (8), the cyclometallated compounds [M{1-(Fc-CH2)-(3-C6H4)-5-Ph-(C3HN2)}Cl(L)] {with M = Pt and L = dmso (5) or PPh3 (6) or M = Pd and L = PPh3 (9)} and the palladium(II) complex [Pd{1-[(eta(5)-C5H4)Fe{(eta(5)-C5H4)-CH2]-3,5-Ph-2-(C3HN2)}Cl(PPh3)] (10) that arises from a transannulation process. The crystal structures of the free ligand 2 and compounds 4, 7, 9 and 10 are also reported and confirm the cis-disposition of the Cl- ligands in 4 and 7, the trans-arrangement of the phosphorous and the nitrogen atoms in 9 and 10, the mode of binding of the ligand in 4, 7, 9 and 10 and the nature of the metallated carbon atom {C(sp(2), phenyl) in 9 or the C(sp(2), ferrocenyl) of the C5H5 ring in 10}. In order to rationalize the different nature of the products isolated in the reactions of 2 with Pd(AcO)(2) or Na-2[PdCl4] and NaAcO density functional theory (DFT) calculations of the complexes have also been carried out

Experimental and Theoretical Studies of the Factors Affecting the Cycloplatination of the Chiral Ferrocenylaldimine (SC)-[(η5-C5H5)Fe{(η5-C5H4) C(H)=N CH(Me)(C6H5)}]

The study of the reactivity of the enantiopure ferrocenyl Schiff base (SC)-[FcCH=N CH(Me)(C6H5)] (1) (Fc = (η5-C5H5)Fe(η5-C5H4)) with cis-[PtCl2(dmso)2] under different experimental conditions is reported. Four different types of chiral Pt(II) have been isolated and characterized. One of them is the enantiomerically pure trans-(SC)-[Pt{κ1-N[FcCH=N CH(Me)(C6H5)]}Cl2(dmso)] (2a) in which the imine acts as a neutral N-donor ligand; while the other three are the cycloplatinated complexes: [Pt{κ2-C,N [(C6H4) N=CHFc]}Cl(dmso)] (7a) and the two diastereomers {(Sp,SC) and (Rp,SC)} of [Pt{κ2-C,N[(η5-C5H3) CH=N {CH(Me)(C6H5)}]Fe(η5-C5H5)}Cl(dmso)] (8a and 9a, respectively). Isomers 7a-9a, differ in the nature of the metallated carbon atom [CPh (in 7a) or CFc (in 8a and 9a)] or the planar chirality of the 1,2-disubstituted ferrocenyl unit (8a and 9a). Reactions of 7a 9a with PPh3 gave [Pt{κ2-C,N[(C6H4) N=CHFc]}Cl(PPh3)] (in 7b) and the diastereomers (Sp,SC) and (Rp,SC) of [Pt{κ2-C,N[(η5-C5H3) CH=N {CH(Me)(C6H5)}] Fe(η5-C5H5)}Cl(PPh3)] (8b and 9b, respectively). Comparative studies of the electrochemical properties and cytotoxic activities on MCF7 and MDA-MB231 breast cancer cell lines of 2a and cycloplatinated complexes 7b-9b are also reported. Theoretical studies based on DFT calculations have also been carried out in order to rationalize the results obtained from the cycloplatination of 1, the stability of the Pt(II) complexes and their electrochemical properties

A study of the properties, reactivity and anticancer activity of novel N- methylated-3-thiazolyl or 3-thienyl carbazoles and their Pd(II) and Pt(II) complexes

The synthesis and characterization of two hybrid N-methylated carbazole derivatives containing a thiazolyl or a thienyl ring is reported. The thiazolyl derivative has been also characterised by X-ray diffraction analysis. The study of its reactivity in front of [MCl2(dmso)(2)] (M = Pd or Pt) or Na-2[PdCl4] in methanol has allowed us to isolate and characterize its complexes. However, for the thienyl analogue, the formation of any Pd(II) or Pt(II) complex was not detected, indicating that it is less prone to bind to the M(II) ions than its thiazolyl analogue. Density Functional Theory (DFT) and Time-Dependent Density Functional Theory (TD-DFT) calculations have also been carried out in order to rationalize the influence of the nature of the thiazolyl or thienyl group on the electronic delocalization. Molecular mechanics calculations show that the free rotation of the thiazolyl in relation to the carbazole requires a greater energy income than for its thienyl analogue. Studies of the cytotoxic activity of the new compounds on colon (HCT116) and breast (MDA-MB231 and MCF7) cancer cell lines show that the thiazolyl carbazole ligand and its Pt(II) complex are the most active agents of the series and in the MCF7 line their potency is higher than that of cisplatin. In the non-tumoral human skin fibroblast BJ cell line, all the compounds were less toxic than cisplatin. Their potential ability to modify the electrophoretic mobility of pBluescript SK+ plasmid DNA and to act as inhibitors of Topoisomerases I and II alpha or cathepsin B has also been investigated

Isomeric and hybrid ferrocenyl/cyrhetrenylaldimines: a new family of multifunctional compounds

The synthesis and characterization of two novel and isomeric hybrid ferrocenyl/cyrhetrenyl aldimines [(η5-C5H5)Fe{(η5-C5H4)-CHvN-(η5-C5H4)}Re(CO)3] (1) and [(η5-C5H5)Fe{(η5-C5H4)-NvCH-(η5-C5H4)}Re (CO)3] (2) are reported. Their X-ray crystal structures reveal that both adopt the E form. However, molecules of 1 and 2 differ in the relative arrangement of the 'Fe(η5-C5H5)' and 'Re(CO)3' units (anti in 1 and syn in 2). This affects the type of intermolecular interactions, the assembly of the molecules and therefore their crystal architecture. Comparative studies of their electrochemical, spectroscopic and photo-physical properties have allowed us to clarify the effect produced by the location of the organometallic arrays (ferrocenyl or cyrhetrenyl) on electronic delocalization, the proclivity of the metals to undergo oxidation and their emissive properties. Theoretical studies based on Density Functional Theory (DFT) calculations on the two compounds have also been carried out in order to rationalize the experimental results and to assign the bands detected in their electronic spectra. The cytotoxic activities of compounds 1 and 2 against human adenocarcinoma cell lines [breast (MCF7 and MDA-MB-231) and colon (HCT-116)] reveal that imine 2 has a greater inhibitory growth effect than 1 and it is ca. 1.8 times more potent than cisplatin in the triple negative MDA-MB 231 and in the cisplatin resistant HCT-116 cell lines. A comparative study of their effect on the normal and non-tumour human skin fibroblast BJ cell lines is also reported

A novel type of organometallic 2-R-2,4-dihydro- 1H-3,1-benzoxazine with R = [M(η5-C5H4)(CO)3] (M = Re or Mn) units. Experimental and computational studies of the effect of substituent R on ring-chain tautomerism

The syntheses, characterization, X-ray crystal structures, electrochemical properties and anticancer and 35 antichagasic activities of the first examples of 2-substituted 2,4-dihydro-1H-3,1-benzoxazines with 36 halfsandwich organometallic arrays, [M(η5-C5H4)(CO)3] (M = Re or Mn), at position-2 are described. 37 Experimental and computational studies based on DFT calculations on the open forms [Schiff bases of 38 general formulae R-CHvN-C6H4-2-CH2OH] (5), with R = ferrocenyl (a), phenyl (b), cyrhetrenyl (c) or 39 cymantrenyl (d), and their tautomeric forms (2-substituted 2,4-dihydro-1H-3,1 benzoxazines) 40 haveallowed us to establish the influence of substituents a-d and solvents on: (a) the extent of 41 tautomeric equilibria (5a-5d) ↔ (6a-6d) and (b) their electrochemical properties and the electronic 42 distribution on the open and closed forms. Despite the formal similarity between 6c and 6d, their 43 anticancer and antiparasitic activities are markedly different. Compound 6d is inactive in the HCT116, 44 MDA-MB231 and MCF7 cancer cell lines, but 6c shows moderate activity in the latter cell line, while 45 the Mn(I) complex (6d) is a more potent anti-Trypanosoma cruzi agent than its Re(I) analogue (6c)

A New Family of Doubly Cyclopalladated Diimines. A Remarkable Effect of the Linker between the Metalated Units on Their Cytotoxicity

The cyclopalladation of a series of symmetric diimines with the formula (RC6H4CHNZ)2, where Z = CH2 or (CH2)2OCH2 and R = p-Cl, p-OMe, p-NO2, and o-Cl, is described. Optimal conditions to obtain the dimetalated compounds were found to be palladium(II) acetate, in toluene, at 60 °C and with a reaction time of 2−4 h. The reactivity of the dimetalated compounds with monodentate, bidentate, and bis(monodentate) Lewis bases was also studied. The cytotoxic activity of some selected compounds was evaluated against a panel of adenocarcinoma cell lines (colon HCT116 and breast MCF7 and MDA-MB231). Compounds containing the fragment NCH2CH2OCH2CH2OCH2CH2N exhibited a remarkable cytotoxic activity in the three cancer cells assayed, but complexes containing the NCH2CH2N fragment showed no activity. It seems that the length and flexibility of the central saturated chain in the imine molecule, as well as its lipophilicity and hydrophilicity, explain the different cytotoxicity of the two series of coordination compounds here reported

Room-Temperature Phosphorescence and Efficient Singlet Oxygen Production by Cyclometalated Pt(II) Complexes with Aromatic Alkynyl Ligands

The synthesis of five novel cyclometalated platinum(II) compounds containing five different alkynyl-chromophores was achieved by the reaction of the previously synthesized Pt-Cl cyclometalated compound (1) with the corresponding RC (math)CH by a Sonogashira reaction. It was observed that the spectral and photophysical characteristics of the cyclometalated platinum(II) complexes (Pt-Ar) are essentially associated with the platinum-cyclometalated unit. Room-temperature emission of the Pt-Ar complexes was attributed to phosphorescence in agreement with DFT calculations. Broad nanosecond (ns)-transient absorption spectra were observed with decays approximately identical to those obtained from the emission of the triplet state. From the femtosecond-transient absorption (fs-TA) data, two main excited- state decay components were identified: one in the order of a few picoseconds was assigned to fast intersystem crossing to populate the triplet excited-state and the second (hundreds of ns) was associated with the decay of the transient triplet state. In general, efficient singlet oxygen photosensitization quantum yields were observed from the triplet state of these complexes

Neutral and ionic platinum compounds containing a cyclometalated chiral primary amine: Synthesis, antitumor activity, DNA interaction and topoisomerase I - cathepsin B inhibition

The synthesis and preliminary biological evaluation of neutral and cationic platinum derivatives of chiral 1-(1-naphthyl)ethylamine are reported, namely cycloplatinated neutral complexes [PtCl{(R or S)-NH(2)CH(CH(3))C(10)H(6)}(L)] [L = SOMe(2) ( 1-R or 1-S ), L = PPh(3) (2-R or 2-S), L = P(4-FC(6)H(4))(3) (3-R), L = P(CH(2))(3)N(3)(CH(2))(3) (4-R)], cycloplatinated cationic complexes [Pt{(R)-NH(2)CH(CH(3))C(10)H(6)}{L}]Cl [L = Ph(2)PCH(2)CH(2)PPh(2) (5-R), L = (C(6)F(5))(2)PCH(2)CH(2)P(C(6)F(5))(2) (6-R)] and the Pt(ii) coordination compound trans-[PtCl(2){(R)-NH(2)CH(CH(3))C(10)H(6)}(2)] (7-R). The X-ray molecular structure of 7-R is reported. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), cell cycle arrest and apoptosis, DNA interaction, topoisomerase I and cathepsin B inhibition, and Pt cell uptake of the studied compounds are presented. Remarkable cytotoxicity was observed for most of the synthesized Pt(ii) compounds regardless of (i) the absolute configuration R or S, and (ii) the coordinated/cyclometallated (neutral or cationic) nature of the complexes. The most potent compound 2-R (IC(50) = 270 nM) showed a 148-fold increase in potency with regard to cisplatin in HCT-116 colon cancer cells. Preliminary biological results point out to different biomolecular targets for the investigated compounds. Neutral cyclometallated complexes 1-R and 2-R, modify the DNA migration as cisplatin, cationic platinacycle 5-R was able to inhibit topoisomerase I-promoted DNA supercoiling, and Pt(ii) coordination compound 7-R turned out to be the most potent inhibitor of cathepsin B. Induction of G-1 phase ( 2-R and 5-R ), and S and G-2 phases (6-R) arrests are related to the antiproliferative activity of some representative compounds upon A-549 cells. Induction of apoptosis is also observed for 2-R and 6-R